Accuray Inc
- Last sale
- Nov 12, 2026 · -4.57%
- Market cap
- $376.11M
- 120.16M shares
- Filings
- 1,034
Q1 2027−12.3% FY26 yoy
Q1 2027N/M FY26 yoy
Q1 2027N/M FY26 yoy
Q1 2027derivedN/M FY26 yoy
Q1 2027N/M FY25 yoy
Q1 2027−29.2% FY26 yoy
- $376.11M
- —
- 1.0×
- 7.1×
- -7.19%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2026 | 2026-06-30 | $401,947,000 | reported | |
| FY 2025 | 2025-06-30 | $458,505,000 | reported | |
| FY 2024 | 2024-06-30 | $446,551,000 | reported | |
| FY 2023 | 2023-06-30 | $447,605,000 | reported | |
| FY 2022 | 2022-06-30 | $429,909,000 | reported | |
| FY 2021 | 2021-06-30 | $396,289,000 | reported | |
| FY 2020 | 2020-06-30 | $382,928,000 | reported | |
| FY 2019 | 2019-06-30 | $418,785,000 | reported | |
| FY 2018 | 2018-06-30 | $404,897,000 | reported | |
| FY 2017 | 2017-06-30 | $383,414,000 | reported | |
| FY 2016 | 2016-06-30 | $398,800,000 | reported | |
| FY 2015 | 2015-06-30 | $379,801,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2023 | — | $0.00 | $0.00 | — | 100.19M sh | +7.2% | 0.0% |
| FY2022 | — | $0.00 | $0.00 | — | 93.50M sh | ±0.0% | — |
| FY2021 | — | $14.08M | $14.08M | — | 93.50M sh | +2.5% | 38.9% |
| FY2020 | — | $0.00 | $0.00 | — | 91.20M sh | +2.7% | — |
Segments
LineFY2026ShareChange
EIMEA$150.91M38%+4.6%
Americas$89.96M22%+1.3%
CHINA$68.14M17%−45.3%
Asia Pacific$48.68M12%+2.7%
JAPAN$44.26M11%−17.5%
Asia Pacific, excluding China———
Asia Pacific, excluding Japan and China———
Europe, India, Middle East and Africa———
Total$401.95M
Surgical & medical instruments & apparatus
Accuray Inc is the 33rd largest of the 144 covered companies the SEC files under this code, by revenue. SIC 3841
CompanyRevenueGrowthNet marginMarket cap
ATRCAtriCure, Inc.$534.5M14.9%2.1%$2.9BGKOSGlaukos Corp$507.4M32.3%37.0%$14.6BAORTArtivion, Inc.$441.3M13.6%2.2%$945.5MMDXGMimedx Group, Inc.$418.6M20.0%11.6%$471.3M
ARAYAccuray Inc (this company)$401.9M12.3%12.2%$376.1M
TCMDTactile Systems Technology Inc$329.5M12.5%5.8%$601.3MANGOAngiodynamics Inc$320.2M9.5%11.5%$511.8MPRCTPROCEPT BioRobotics Corp$308.1M37.2%31.0%$1.4BSKINSkinHealth Systems Inc.$300.8M10.0%3.2%$106.2MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Accuray Inc · CIK 1138723 · Engraved from SEC EDGAR